Growth-hormone secretagogues and muscle/IGF compounds - from CJC-1295 and ipamorelin to IGF-1 and follistatin.
Long-acting GHRH analog
A GHRH(1-29) analog modified with a Drug Affinity Complex (DAC) that binds albumin so it lasts ~6-8 days in the body.
Short-acting GHRH analog
The same modified GHRH(1-29) peptide without the albumin-binding DAC, so it clears fast (~30 min) - sold as 'Mod GRF 1-29'.
GH secretagogue / ghrelin mimetic
A selective synthetic pentapeptide that stimulates the body's own GH release via the ghrelin receptor.
GHRH analog - GHRH
A 29-amino-acid peptide identical to the active fragment of natural GHRH; historically an FDA-approved drug (Geref).
GHRH analog
A stabilized synthetic GHRH analog marketed as Egrifta / Egrifta SV / Egrifta WR - the only fully FDA-approved compound in this GH group.
GH secretagogue / ghrelin mimetic
A synthetic hexapeptide that potently stimulates the body's own GH release via the ghrelin receptor; more potent than GHRP-6 with less hunger.
GH secretagogue / ghrelin mimetic
A synthetic hexapeptide that stimulates GH release via the ghrelin receptor and strongly stimulates appetite.
Synthetic hexapeptide growth hormone-releasing peptide
Hexarelin is a potent synthetic peptide that stimulates the body to release its own growth hormone.
Pegylated mechano growth factor
PEG-MGF is a longer-lasting, pegylated version of mechano growth factor, a muscle-specific splice variant of IGF-1.
Long-acting synthetic analog of insulin-like growth factor 1
IGF-1 LR3 is a modified, long-acting version of IGF-1 designed to stay active in the body far longer than natural IGF-1.
Soluble ActRIIB-Fc fusion protein / myostatin
ACE-031 is an experimental biologic decoy receptor that blocks myostatin to promote muscle growth.
Follistatin isoform
Follistatin-344 is a form of the natural protein follistatin that blocks myostatin and activin to allow greater muscle growth.